Alcohol increases breast cancer recurrence risks after early diagnosis

Article

Among women with a previous diagnosis of early state breast cancer, just 3 to 4 alcholic drinks per week could increase their risk for disease recurrence and death, especially if they are postmenopausal, overweight or obese.

Among women with a previous diagnosis of early-stage breast cancer, just 3 to 4 alcoholic drinks per week could increase their risks for disease recurrence and death, especially if they are postmenopausal, overweight, or obese.

Researchers administered a survey on alcohol use to 1,897 early-stage breast cancer survivors diagnosed during 1997 to 2000 who participated in the Life After Cancer Epidemiology study. The researchers then followed the participants for an average of about 7 years. Compared with no drinking, the authors of the study determined that consuming 6 g per day or more of alcohol was associated with an increased risk for breast cancer recurrence (HR, 1.35; 95% CI, 1.00-1.83) and death because of breast cancer (HR, 1.51; 95% CI, 1.00-2.29). Recurrence risk was higher for postmenopausal women (HR, 1.51; 95% CI, 1.05-2.19) and women who were overweight or obese (HR, 1.60; 95% CI, 1.08-2.38).

However, alcohol consumption was not associated with all-cause death and was possibly associated with a decreased risk for non-breast cancer death, alluding to its cardioprotective effects.

Recent Videos
1 expert is featured in this series.
Giovanni Traverso, PhD, highlights contraceptive implants through small needle | Image Credit: meche.mit.edu
Ryan Haumschild, PharmD
1 expert is featured in this series.
How sex differences impact treatment efficacy for chronic pain | Image Credit: profiles.ucalgary.ca.
Tuan Trang, PhD, discusses biological differences in chronic pain between men and women | Image Credit: profiles.ucalgary.ca.
1 expert is featured in this series.
How the Flyte device revolutionizes SUI management | Image Credit: linkedin.com.
Dr. Wanda Filer discusses how to overcome barriers to SUI treatment | Image Credit: linkedin.com.
Revi System shows efficacy against urgency urinary incontinence | Image Credit: ics.org.
© 2025 MJH Life Sciences

All rights reserved.